IL-1β, IL-2, IL-6 and TNF-α production by peripheral blood mononuclear cells from patients with Parkinson's disease

[1]  T. Nagatsu,et al.  Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease , 1996, Neuroscience Letters.

[2]  M. Pawlikowski,et al.  Evaluation of interleukins, ACTH, cortisol and prolactin concentrations in the blood of patients with parkinson's disease. , 1996, Neuroimmunomodulation.

[3]  Peter Riederer,et al.  Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients , 1995, Neuroscience Letters.

[4]  H. Stolze,et al.  Defective production of interleukin-2 in patients with idiopathic Parkinson's disease , 1995, Journal of the Neurological Sciences.

[5]  Y. Agid.  [Aging, disease and nerve cell death]. , 1995, Bulletin de l'Academie nationale de medecine.

[6]  P. Lapchak,et al.  Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: Selective effects on specific interleukins and interleukin receptors , 1994, Neuroscience.

[7]  E. Hirsch,et al.  Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease , 1994, Neuroscience Letters.

[8]  T. Olsson,et al.  γδ + T cells are increased in patients with Parkinson's disease , 1994, Journal of the Neurological Sciences.

[9]  A. Członkowska,et al.  The immunological status in Parkinson's disease. , 1991, Medical laboratory sciences.

[10]  E. Soppi,et al.  Immune functions in Parkinson's disease lymphocyte subsets, concanavalin A-induced suppressor cell activity and in vitro immunoglobulin production , 1985, Journal of the Neurological Sciences.

[11]  W. Kuhn,et al.  Neuroimmune mechanisms in Parkinson's disease. , 1995, Journal of neural transmission. Supplementum.

[12]  R. Marttila,et al.  Immune functions in Parkinson's disease. , 1984, Advances in neurology.